Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Treatment with anti‐OX40L or anti‐TSLP does not...
Journal article

Treatment with anti‐OX40L or anti‐TSLP does not alter the frequency of T regulatory cells in allergic asthmatics

Abstract

OX40-OX40L interactions and thymic stromal lymphopoietin (TSLP) are important in the induction and maintenance of Th2 responses in allergic disease, whereas T regulatory cells (Treg) have been shown to suppress pro-inflammatory Th2 responses. Both OX40L and TSLP have been implicated in the negative regulation of Treg. The effect of anti-asthma therapies on Treg is not well known. Our aim was to assess the effects of two monoclonal antibody …

Authors

Baatjes AJ; Smith SG; Dua B; Watson R; Gauvreau GM; O'Byrne PM

Journal

Allergy, Vol. 70, No. 11, pp. 1505–1508

Publisher

Wiley

Publication Date

November 2015

DOI

10.1111/all.12708

ISSN

0001-5148